Explore more publications!
American Consumer Products Digest
Got News to Share?

Press Releases

Ebadat Publishes First-of-Its-Kind Legal Guide for U.S. Investors in European Football
3 hours ago

Ebadat Publishes First-of-Its-Kind Legal Guide for U.S. Investors in European Football

Neutral EIN Presswire
Vertiv Announces Expansion of Two Ohio Facilities, Including U.S. Headquarters
2 hours ago

Vertiv Announces Expansion of Two Ohio Facilities, Including U.S. Headquarters

Indeterminate GlobeNewswire, Inc.
GenerMotor Unveils Rack-Adjacent HVDC Technology to Secure U.S. AI Power Sovereignty
7 hours ago

GenerMotor Unveils Rack-Adjacent HVDC Technology to Secure U.S. AI Power Sovereignty

Neutral EIN Presswire
Hudson Motor Company Returns Under New Ownership With Plans for U.S. Manufacturing
8 hours ago

Hudson Motor Company Returns Under New Ownership With Plans for U.S. Manufacturing

Neutral EIN Presswire
2026 Consumer Trust Survey: 73% of Americans Say Their Internet Bill Increased This Year
4 hours ago

2026 Consumer Trust Survey: 73% of Americans Say Their Internet Bill Increased This Year

Neutral EIN Presswire
SNOW's Generic Risk Warnings Allegedly Failed to Disclose Known Headwinds — Levi & Korsinsky, LLP
an hour ago

SNOW's Generic Risk Warnings Allegedly Failed to Disclose Known Headwinds — Levi & Korsinsky, LLP

Indeterminate GlobeNewswire, Inc.
Xtra Responds to Creator Demand for Extra Camera Choices, Outlines Future Product Strategy for Xtra Muse and Xtra Atto
3 hours ago

Xtra Responds to Creator Demand for Extra Camera Choices, Outlines Future Product Strategy for Xtra Muse and Xtra Atto

Indeterminate GlobeNewswire, Inc.
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
2 hours ago

Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

Indeterminate GlobeNewswire, Inc.
Image Sensing Systems, Inc. Expands Agreement with Econolite Control Products, Inc, Strengthens Partnership
2 hours ago

Image Sensing Systems, Inc. Expands Agreement with Econolite Control Products, Inc, Strengthens Partnership

Indeterminate GlobeNewswire, Inc.
REalloys (NASDAQ: ALOY) Appoints Former Chief of Staff to the U.S. Secretary of Defense Joe Kasper as Chair of Its Advisory Board
9 hours ago

REalloys (NASDAQ: ALOY) Appoints Former Chief of Staff to the U.S. Secretary of Defense Joe Kasper as Chair of Its Advisory Board

Indeterminate GlobeNewswire, Inc.
Dayforce Advances FedRAMP Authorization to Deepen Commitment to U.S. Federal Agencies
9 hours ago

Dayforce Advances FedRAMP Authorization to Deepen Commitment to U.S. Federal Agencies

Indeterminate GlobeNewswire, Inc.
JFB Announces XTEND Becomes First U.S. Company to Receive U.S. Army Safety Board Approval for FPV Drone Programs
10 hours ago

JFB Announces XTEND Becomes First U.S. Company to Receive U.S. Army Safety Board Approval for FPV Drone Programs

Indeterminate GlobeNewswire, Inc.
U.S. Surveillance Drone Market Set to Reach US$ 4.5 Bn by 2033 Driven by AI Integration and Rising Security Demands
12 hours ago

U.S. Surveillance Drone Market Set to Reach US$ 4.5 Bn by 2033 Driven by AI Integration and Rising Security Demands

Neutral EIN Presswire
Victoria Cruise Lines Opens 2026 with World’s Largest River Cruise Ships with Launch of 590-Passenger Victoria Isabella
5 hours ago

Victoria Cruise Lines Opens 2026 with World’s Largest River Cruise Ships with Launch of 590-Passenger Victoria Isabella

Indeterminate GlobeNewswire, Inc.
Willis launches new facility to address limited umbrella capacity in U.S. casualty market
10 hours ago

Willis launches new facility to address limited umbrella capacity in U.S. casualty market

Indeterminate GlobeNewswire, Inc.
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
10 hours ago

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Indeterminate GlobeNewswire, Inc.
Beyond Oil Expands into U.S. Supermarket Vertical with Multi-Phase Commercial Rollout with a Top-Tier U.S. Supermarket Brand
10 hours ago

Beyond Oil Expands into U.S. Supermarket Vertical with Multi-Phase Commercial Rollout with a Top-Tier U.S. Supermarket Brand

Indeterminate GlobeNewswire, Inc.
Virtuix Signs Cooperative Research and Development Agreement with U.S. Navy
10 hours ago

Virtuix Signs Cooperative Research and Development Agreement with U.S. Navy

Indeterminate GlobeNewswire, Inc.
Digital Realty Announces Final Close of $3.25 billion U.S. Hyperscale Data Center Fund
11 hours ago

Digital Realty Announces Final Close of $3.25 billion U.S. Hyperscale Data Center Fund

Indeterminate GlobeNewswire, Inc.
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
12 hours ago

Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions